Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles

NMR in Biomedicine

Volumn 26, Issue 8, 2013, Pages 949-962

  Kim, Seong Gi ^a   Harel, Noam ^b   Jin, Tao ^a   Kim, Tae ^a   Lee, Phil ^c   Zhao, Fuqiang ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cerebral blood volume; Contrast agent; Cortical columns; FMRI; Iron oxide; Monocrystalline iron oxide nanoparticle (MION); Pharmacological MRI; Ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles

Indexed keywords

CEREBRAL BLOOD VOLUME; CONTRAST AGENT; CORTICAL COLUMNS; FMRI; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

HEMODYNAMICS; IRON OXIDES; METAL NANOPARTICLES; PHYSIOLOGICAL MODELS;

SUPERPARAMAGNETISM;

CONTRAST MEDIUM; GADOLINIUM; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN BLOOD VESSEL; BRAIN BLOOD VOLUME; CAT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; HEMATOCRIT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY; STEADY STATE;

ANIMALIA;

CEREBRAL BLOOD VOLUME; CONTRAST AGENT; CORTICAL COLUMNS; FMRI; IRON OXIDE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE (MION); PHARMACOLOGICAL MRI; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE (USPIO) NANOPARTICLES;

ANIMALS; ARTERIOLES; BLOOD VOLUME; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DEXTRANS; HALF-LIFE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROCIRCULATION; MOTOR ACTIVITY; NEUROSCIENCES; OXYGEN; SENSITIVITY AND SPECIFICITY; VENULES;

EID: 84880933137     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2885     Document Type: Article

References (109)

1. Johnston DL, Liu P, Lauffer RB, Newell JB, Wedeen VJ, Rosen BR, Brady TJ, Okada RD. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging. J. Nucl. Med. 1987; 28(5): 871-877.
2. Villringer A, Rosen BR, Bellieau JW, Ackerman JL, Lauffer RB, Buxton RB, Chao YS, Wedeen VJ, Brady TJ. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 1988; 6: 164-174.
3. Belliveau JW, Kennedy DN, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991; 254: 716-719.
4. Rosen BR, Belliveau JW, Buchbinder BR, McKinstry RC, Porkka LM, Kennedy DN, Neuder MS, Fisel CR, Aronen HJ, Kwong KK, Weisskoff RF, Cohen MS, Brady TJ. Contrast agents and cerebral hemodynamics. Magn. Reson. Med. 1991; 19(2): 285-292.
5. Willats L, Calamante F. The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI. NMR Biomed 2012; DOI: 10.1002/nbm.2833.
6. Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006; 58(14): 1471-1504.
7. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175: 489-493.
8. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994; 32(6): 749-763.
9. Kiselev VG, Posse S. Analytical model of susceptibility-induced MR signal dephasing: effect of diffusion in a microvascular network. Magn. Reson. Med. 1999; 41: 499-509.
10. Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann JM, Ugurbil K. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys. J. 1993; 64(3): 803-812.
11. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn. Reson. Med. 1994; 31: 601-610.
12. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic perturbations. Magn. Reson. Med. 1995; 34: 555-566.
13. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn. Reson. Med. 1998; 40: 793-799.
14. Tropres I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Decorps M. Vessel size imaging. Magn. Reson. Med. 2001; 45: 397-408.
15. Berry I, Benderbous S, Ranjeva J-P, Gracia-Meavilla D, Manelfe C, Le Bihan D. Contribution of Sinerem used as blood-pool contrast agent: detection of cerebral blood volume changes during apnea in the rabbit. Magn. Reson. Med. 1996; 36: 415-419.
16. Kennan RP, Scanley BE, Innis RB, Gore JC. Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects. Magn. Reson. Med. 1998; 40: 840-846.
17. Mandeville JB, Marota JJ, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR, Weisskoff RM. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 1998; 39(4): 615-624.
18. van Bruggen N, Busch E, Palmer JT, Williams S-P, de Crespigny AJ. High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media. J. Cereb. Blood Flow Metab. 1998; 18: 1178-1183.
19. Mandeville JB, Marota JJA. Vascular filters of functional MRI: spatial localization using BOLD and CBV contrast. Magn. Reson. Med. 1999; 42: 591-598.
20. Mandeville JB, Jenkins BG, Kosofsky BE, Moskowitz MA, Rosen BR, Marota JJA. Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain. Magn. Reson. Med. 2001; 45: 443-447.
21. Mandeville J, Jenkins B, Chen Y, Choi J-K, Kim Y, Belen D, Liu C, Kosofsky B, Marota JJA. Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn. Reson. Med. 2004; 52: 1272-1281.
22. Mandeville JB. IRON fMRI measurements of CBV and implications for BOLD signal. NeuroImage 2012; 62: 1000-1006.
23. Chen YC, Mandeville JB, Nguyen TV, Talele A, Cavagna F, Jenkins BG. Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents. J. Magn. Reson. Imaging, 2001; 14(5): 517-524.
24. Shen T, Weissleder R, Papisov M, Bogdanov JA, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 1993; 29: 599-604.
25. Wu EX, Tang H, Jensen JH. Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models. NMR Biomed. 2004; 17(7): 478-483.
26. 1 relaxation and blood-myocardial contrast enhancement of NC100150 injection in cardiac MRI. J. Magn. Reson. Imaging 1999; 10(5): 784-789.
27. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M. Long-lasting iron oxides for MR imaging. Adv. Drug Deliv. Rev. 1995; 16: 321-334.
28. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J. Drug Target. 1998; 6(3): 167-174.
29. Vanduffel W, Fize D, Mandeville JB, Nelissen K, van Hecke P, Rosen BR, Tootell RBH, Orban GA. Visual motion processing investigated using contrast agent-enhanced fMRI in awake behaving monkeys. Neuron 2001; 32: 565-577.
30. Leite FP, Tsao D, Vanduffel W, Fize D, Sasaki Y, Wald LL, Dale AM, Kwong K, Orban GA, Rosen B, Tootell RBH, Mandeville JB. Repeated fMRI using iron oxide contrast agent in awake, behaving macaques at 3 Tesla. NeuroImage 2002; 16: 283-294.
31. Li W, Tutton S, Vu AT, Pierchala L, Li BS, Lewis JM, Prasad PV, Edelman RR. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J. Magn. Reson. Imaging 2005; 21(1): 46-52.
32. 2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state - dependence on blood volume and water exchange. Magn. Reson. Med. 2002; 47(3): 461-471.
33. Zhao F, Wang P, Harel N, Nagaoka T, Kim S-G. Contrast agent-enhanced functional magnetic resonance imaging at 4.7T and 9.4T. Proceedings of the 11th Annual Meeting ISMRM, Toronto, ON, Canada, 2003; 1770.
34. Chu SC, Xu Y, Balschi JA, Springer CS Jr. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn. Reson. Med. 1990; 13(2): 239-262.
35. 2, and non-Lorentzian signal behavior. Magn. Reson. Med. 2001; 45: 533-542.
36. Kim T, Masamoto K, Hendrich K, Kim S-G. Arterial versus total blood volume changes during neural activity-induced cerebral blood flow change: implication for BOLD fMRI. J. Cereb. Blood Flow Metab. 2007; 27: 1235-1247.
37. Weisskoff RM, Hoppel BJ, Rosen BR. Signal changes in dynamic contrast studies: theory and experiment in vivo. J. Magn. Reson. Imaging 1992; 2: 77.
38. Weisskoff RM, Kiihne S. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood. Magn. Reson. Med. 1992; 24: 375-383.
39. Kim T, Kim S-G. Quantification of cerebral arterial blood volume and cerebral blood flow using MRI with modulation of tissue and vessel (MOTIVE) signals. Magn. Reson. Med. 2005; 54: 333-342.
40. Anzai Y, Prince MR, Chenevert TL, Maki JH, Londy F, London M, McLachlan SJ. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J. Magn. Reson. Imaging 1997; 7(1): 209-214.
41. 2*) and contrast agent (MION) dose. J. Magn. Reson. Imaging 2003; 18(4): 397-403.
42. Bolan PJ, Yacoub E, Garwood M, Ugurbil K, Harel N. In vivo micro-MRI of intracortical neurovasculature. NeuroImage 2006; 32(1): 62-69.
43. Kim T, Kim S-G. Temporal dynamics and spatial specificity of arterial and venous blood volume changes during visual stimulation: implication for BOLD quantification. J. Cereb. Blood Flow Metab. 2011; 31(5): 1211-1222.
44. Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J. Cereb. Blood Flow Metab. 1985; 5: 65-69.
45. Zhao F, Wang P, Hendrich K, Ugurbil K, Kim S-G. Cortical layer-dependent BOLD and CBV responses measured by spin-echo and gradient-echo fMRI: insights into hemodynamic regulation. NeuroImage 2006; 30: 1149-1160.
46. Tieman S, Mollers S, Tieman D, White J. The blood supply of the cat's visual cortex and its postnatal development. Brain Res. 2004; 998(1): 100-112.
47. Le Duc G, Peoc'h M, Remy C, Charpy O, Muller RN, Le Bas JF, Decorps M. Use of T(2)-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain. Magn. Reson. Med. 1999; 42(4): 754-761.
48. Wu EX, Wong KK, Andrassy M, Tang H. High-resolution in vivo CBV mapping with MRI in wild-type mice. Magn. Reson. Med. 2003; 49(4): 765-770.
49. 2 with MION infusion. Magn. Reson. Med. 2004; 51: 55-61.
50. Jensen J, Chandra R. MR imaging of microvasculature. Magn. Reson. Med. 2000; 44: 224-230.
51. Tropres I, Lamalle L, Peoch M, Farion R, Usson Y, Decorps M, Remy C. In vivo assessment of tumoral angiogenesis. Magn. Reson. Med. 2004; 51: 533-541.
52. Ungersma SE, Pacheco G, Ho C, Yee SF, Ross J, van Bruggen N, Peale FV Jr, Ross S, Carano RA. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn. Reson. Med. 2010; 63(6): 1637-1647.
53. Douma K, Oostendorp M, Slaaf DW, Post MJ, Backes WH, van Zandvoort MA. Evaluation of magnetic resonance vessel size imaging by two-photon laser scanning microscopy. Magn. Reson. Med. 2010; 63(4): 930-939.
54. Kennan RP, Scanley E, Gore JC. Physiological basis for BOLD MR signal changes due to hypoxia/hyperoxia: separation of blood volume and magnetic susceptibility effects. Magn. Reson. Med. 1997; 37: 953-956.
55. Lu H, Scholl CA, Zuo Y, Stein EA, Yang Y. Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T. Magn. Reson. Med. 2007; 58(3): 616-621.
56. Harel N, Zhao F, Wang P, Kim S-G. Cortical layer specificity of BOLD and CBV fMRI signals at ultra-high resolution. Proceedings of the 10th Annual Meeting ISMRM, Honolulu, HI, USA, 2002; 9.
57. Payne BR, Peters A. The concept of cat primary visual cortex. In: Payne BR, Peters A, Editors. The Cat Primary Visual Cortex. Academic Press: San Diego; 2002, pp. 1-129.
58. Harel N, Lin J, Moeller S, Ugurbil K, Yacoub E. Combined imaging-histological study of cortical laminar specificity of fMRI signals. NeuroImage, 2006; 29: 879-887.
59. Mandeville JB, Leite FP, Marota JJ. Spin-echo MRI underestimates functional changes in microvascular cerebral blood plasma volume using exogenous contrast agent. Magn. Reson. Med. 2007; 58(4): 769-776.
60. Van Camp N, Peeters RR, Van der Linden A. A comparison between blood oxygenation level-dependent and cerebral blood volume contrast in the rat cerebral and cerebellar somatosensoric cortex during electrical paw stimulation. J. Magn. Reson. Imaging 2005; 22(4): 483-491.
61. Qiu D, Zaharchuk G, Christen T, Ni WW, Moseley ME. Contrast-enhanced functional blood volume imaging (CE-fBVI): enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol. NeuroImage 2012; 62: 1726-1731.
62. Smirnakis SM, Schmid MC, Weber B, Tolias AS, Augath M, Logothetis NK. Spatial specificity of BOLD versus cerebral blood volume fMRI for mapping cortical organization. J. Cereb. Blood Flow Metab. 2007; 27(6): 1248-1261.
63. Keilholz SD, Silva AC, Raman M, Merkle H, Koretsky AP. BOLD and CBV-weighted functional magnetic resonance imaging of the rat somatosensory system. Magn. Reson. Med. 2006; 55(2): 316-324.
64. Lee SP, Harel N, Nagaoka T, Kim S-G. Quantification of relative CBV changes during neural stimulation. Proc. Int. Soc. Magn. Reson. Med. 2002; 10: 644.
65. Mandeville JB, Marota J, Ayata C, Zaharchuk G, Moskowitz M, Rosen BR, Weisskoff RM. Evidence of a cerebrovascular postarteriole windkessel with delayed compliance. J. Cereb. Blood Flow Metab. 1999; 19: 679-689.
66. Silva AC, Koretsky A, Duyn J. Functional MRI impulse response for BOLD and CBV contrast in rat somatosensory cortex. Magn. Reson. Med. 2007; 57: 1110-1118.
67. Lu H, Soltysik DA, Ward BD, Hyde JS. Temporal evolution of the CBV-fMRI signal to rat whisker stimulation of variable duration and intensity: a linearity analysis. NeuroImage 2005; 26(2): 432-440.
68. Jin T, Kim S-G. Cortical layer-dependent dynamic blood oxygenation, cerebral blood flow and cerebral blood volume responses during visual stimulation. NeuroImage 2008; 43: 1-9.
69. Palmer J, de Crespigny A, Williams S-P, Busch E, van Bruggen N. High-resolution mapping of discrete represenational areas in rat somatosensory cortex using blood volume-dependent functional MRI. NeuroImage 1999; 9: 383-392.
70. Lu H, Patel S, Luo F, Li SJ, Hillard CJ, Ward BD, Hyde JS. Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression. Magn. Reson. Med. 2004; 52(5): 1060-1068.
71. Zhao F, Wang P, Hendrich K, Kim S-G. Spatial specificity of cerebral blood volume-weighted fMRI responses at columnar resolution. NeuroImage 2005; 27: 416-424.
72. Fukuda M, Moon C-H, Wang P, Kim S-G. Mapping iso-orientation columns by contrast agent-enhanced functional MRI: reproducibility, specificity and evaluation by optical imaging of intrinsic signal. J. Neurosci. 2006; 26: 11 821-11 832.
73. Kim D-S, Duong TQ, Kim S-G. High-resolution mapping of iso-orientation columns by fMRI. Nat. Neurosci. 2000; 3: 164-169.
74. Hubel DH, Wiesel TN. Receptive fields, binocular interaction and functional architecture in the cat's visual cortex. J. Physiol. London 1962; 160: 215-243.
75. Hamberg LM, Boccalini P, Stranjalis G, Hunter GJ, Huang Z, Halpern E, Weisskoff RM, Moskowitz MA, Rosen BR. Continuous assessment of relative cerebral blood volume in transient ischemia using steady state susceptibility-contrast MRI. Magn. Reson. Med. 1996; 35: 168-173.
76. de Crespigny AJ, Rother J, Beaulieu C, Neumann-Haefelin T, Moseley ME. Comparison of diffusion, blood oxygenation, and blood volume changes during global ischemia in rats. Magn. Reson. Med. 2001; 45(1): 10-16.
77. Kim YR, Huang IJ, Lee SR, Tejima E, Mandeville JB, van Meer MP, Dai G, Choi YW, Dijkhuizen RM, Lo EH, Rosen BR. Measurements of BOLD/CBV ratio show altered fMRI hemodynamics during stroke recovery in rats. J. Cereb. Blood Flow Metab. 2005; 25(7): 820-829.
78. Payen JF, Vath A, Koenigsberg B, Bourlier V, Decorps M. Regional cerebral plasma volume response to carbon dioxide using magnetic resonance imaging. Anesthesiology 1998; 88(4): 984-992.
79. Payen JF, Briot E, Tropres I, Julien-Dolbec C, Montigon O, Decorps M. Regional cerebral blood volume response to hypocapnia using susceptibility contrast MRI. NMR Biomed. 2000; 13(7): 384-391.
80. Broux C, Tropres I, Montigon O, Julien C, Decorps M, Payen JF. The effects of sustained hyperventilation on regional cerebral blood volume in thiopental-anesthetized rats. Anesth. Analg. 2002; 95(6): 1746-1751.
81. Julien-Dolbec C, Tropres I, Montigon O, Reutenauer H, Ziegler A, Decorps M, Payen JF. Regional response of cerebral blood volume to graded hypoxic hypoxia in rat brain. Br. J. Anaesth. 2002; 89(2): 287-293.
82. 2 during rat forepaw stimulation. Magn. Reson. Med. 1999; 42: 944-951.
83. Hyder F, Kida I, Behar KL, Kennan RP, Maciejewski PK, Rothman DL. Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI. NMR Biomed. 2001; 14: 413-431.
84. Wu G, Luo F, Li Z, Zhao X, Li SJ. Transient relationships among BOLD, CBV, and CBF changes in rat brain as detected by functional MRI. Magn. Reson. Med. 2002; 48(6): 987-993.
85. 2 fMRI signal temporal dynamics at 500-msec resolution. J. Magn. Reson. Imaging 2008; 27(3): 599-606.
86. Shih YY, Wey HY, De La Garza BH, Duong TQ. Striatal and cortical BOLD, blood flow, blood volume, oxygen consumption, and glucose consumption changes in noxious forepaw electrical stimulation. J. Cereb. Blood Flow Metab. 2011; 31(3): 832-841.
87. 2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke 1974; 5: 630-639.
88. Kida I, Rothman DL, Hyder F. Dynamics of changes in blood flow, volume, and oxygenation: implications for dynamic functional magnetic resonance imaging calibration. J. Cereb. Blood Flow Metab. 2007; 27(4): 690-696.
89. Lee S-P, Duong T, Yang G, Iadecola C, Kim S-G. Relative changes of cerebral arterial and venous blood volumes during increased cerebral blood flow: implications for BOLD fMRI. Magn. Reson. Med. 2001; 45: 791-800.
90. Zong X, Kim T, Kim S-G. Contributions of dynamic venous blood volume versus oxygenation level changes to BOLD fMRI. NeuroImage 2012; 60(4): 2238-2246.
91. Kim T, Kim S-G. Quantification of cerebral arterial blood volume using arterial spin labeling with intravoxel incoherent motion-sensitive gradients. Magn. Reson. Med. 2006; 55: 1047-1057.
92. Kim T, Hendrich K, Kim S-G. Functional MRI with magnetization transfer effects: determination of BOLD and arterial blood volume changes. Magn. Reson. Med. 2008; 60: 1518-1523.
93. Dubowitz D, Bernheim K, Chen D, Bradley W, Andersen R. Enhancing fMRI contrast in awake-behaving primates using intravascular magnetite dextran nanoparticles. Neuroreport 2001; 12: 2335-2340.
94. Durand JB, Nelissen K, Joly O, Wardak C, Todd JT, Norman JF, Janssen P, Vanduffel W, Orban GA. Anterior regions of monkey parietal cortex process visual 3D shape. Neuron 2007; 55(3): 493-505.
95. Tsao DY, Moeller S, Freiwald WA. Comparing face patch systems in macaques and humans. Proc. Natl. Acad. Sci. USA 2008; 105(49): 19 514-19 519.
96. Mueggler T, Baumann D, Rausch M, Rudin M. Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn. Reson. Med. 2001; 46(2): 292-298.
97. Zhao F, Williams M, Meng X, Welsh DC, Coimbra A, Crown ED, Cook JJ, Urban MO, Hargreaves R, Williams DS. BOLD and blood volume-weighted fMRI of rat lumbar spinal cord during non-noxious and noxious electrical hindpaw stimulation. NeuroImage 2008; 40(1): 133-147.
98. Zhao F, Williams M, Meng X, Welsh DC, Grachev ID, Hargreaves R, Williams DS. Pain fMRI in rat cervical spinal cord: an echo planar imaging evaluation of sensitivity of BOLD and blood volume-weighted fMRI. NeuroImage 2009; 44(2): 349-362.
99. Reese T, Bjelke B, Porszasz R, Baumann D, Bochelen D, Sauter A, Rudin M. Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed. 2000; 13(1): 43-49.
100. Chen YI, Famous K, Xu H, Choi JK, Mandeville JB, Schmidt HD, Pierce RC, Jenkins BG. Cocaine self-administration leads to alterations in temporal responses to cocaine challenge in limbic and motor circuitry. Eur. J. Neurosci. 2011; 34(5): 800-815.
101. Mandeville JB, Choi JK, Jarraya B, Rosen BR, Jenkins BG, Vanduffel W. FMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia. Neuropsychopharmacology 2011; 36(6): 1187-1198.
102. Perles-Barbacaru TA, Procissi D, Demyanenko AV, Hall FS, Uhl GR, Jacobs RE. Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice. NeuroImage 2011; 55(2): 622-628.
103. Chen YC, Choi JK, Andersen SL, Rosen BR, Jenkins BG. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berlin) 2005; 180(4): 705-715.
104. Choi JK, Mandeville JB, Chen YI, Grundt P, Sarkar SK, Newman AH, Jenkins BG. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists. Psychopharmacology (Berlin) 2010; 212(1): 59-72.
105. Choi JK, Mandeville JB, Chen YI, Kim YR, Jenkins BG. High resolution spatial mapping of nicotine action using pharmacologic magnetic resonance imaging. Synapse 2006; 60(2): 152-157.
106. Panizzutti R, Rausch M, Zurbrugg S, Baumann D, Beckmann N, Rudin M. The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain. Neurosci. Lett. 2005; 380(1-2): 111-115.
107. Rausch M, Gentsch C, Enz A, Baumann D, Rudin M. A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects. NMR Biomed. 2005; 18(4): 260-268.
108. Jenkins BG, Sanchez-Pernaute R, Brownell AL, Chen YC, Isacson O. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J. Neurosci. 2004; 24(43): 9553-9560.
109. Ren J, Xu H, Choi JK, Jenkins BG, Chen YI. Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses. Synapse 2009; 63(9): 764-772.